Abstract Submission

Key dates

Abstract submission opensFriday, 11 August 2017
Abstract submission deadline
Wednesday, 18 October 2017, 12:00 CET (noon)
Abstract notificationsWednesday, 15 November 2017

The GTH 2018 abstract submission is now closed. 

Notifications will be sent mid-November 2017. 

Submission instructions

Maximum length of abstract: 250 words
Title limit: 30 words maximum
1 image and 1 table are allowed per abstract. 


All abstracts need to be submitted via the online submission platform

If an abstract is accepted it is mandatory for the presenting author to attend the congress. For an abstract to be included in the final scientific programme, it is mandatory for the presenting author to register for the congress and to settle payment as soon as the notification of abstract acceptance is received and not later than Friday, 24 November 2017. Expenses associated with the preparation, submission and presentation of an abstract are the responsibility of the presenter(s)/author(s).

Abstract topics

1. Pathophysiology of thrombosis
a. Venous
b. Arterial 

2. Diagnosis of VTE 

3. Thrombosis -Treatment 
a. Oral anticoagulants
b. Antiplatelet agents
c. Thrombolytic agents
d. Monitoring antithrombotic therapy
e. Other related topics

4. Vascular wall biology and disorders
a. Endothelial cells
b. Angiogenesis and tissue repair
c. Biorheology
d. Adhesion molecules, including von Willebrand factor
e. Extracellular microvesicles
f. Other related topics

5. Platelets
a. Physiology
b. Acquired thrombocytopenias
c. Inherited thrombocytopenias
d. Platelet dysfunction
e. Other related topics

6. Bleeding disorders, coagulation and fibrinolytic factors
a. Coagulation and fibrinolytic factors - physiology
b. Hemophilia
c. Von Willebrand disease
d. Rare bleeding disorders
e. Treatment of bleedings disorders
f. Other related topics

7. Pediatric and neonatal thrombosis and hemostasis

8. Women issues in thrombosis and hemostasis

9. Acquired disorders and alterations of coagulation
a. DIC, sepsis and other inflammatory conditions
b. Host defense and hemostasis
c. Perioperative hemostasis
d. Transfusion medicine
e. Cancer
f. Acquired hemophilia, acquired von Willebrand disease
g. Other related topics 

10. Laboratory tests
a. Quality control
b. Diagnostic methods
c. Predictive and diagnostic variables
d. Lupus anticoagulant
e. Thrombin generation
f. Issues related to new factor concentrates
g. Other related topics

11. Animal models